Abstract
Overdose deaths in the United States surged from 2018 to 2022 due to the smuggling of fentanyl through ports-of-entry. To combat this epidemic, the U.S. used advanced scanners at southern ports-of-entry, which tripled inspections and improved screening, especially since March 2023. Following March 2023, fentanyl domestic seizures decreased by 29% and fentanyl overdose deaths decreased by 35%. Fentanyl overdose deaths decreased in 90% of states and increased only in states that receive fentanyl through ports-of-entry that lack these scanners. If this decrease in overdose deaths continues until November 2025, the death rate would be lower than at the start of the opioid epidemic. These results support urgent funding for advanced scanners at ports-of-entry that lack them.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available data that were originally located at: https://wonder.cdc.gov/controller/saved/D176/D408F378
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(contact: orenmir{at}post.bgu.ac.il)
Added sections on opioid overdose data and fentanyl seizure data, expanded the fentanyl overdose data to April 2024, clarified the map figure, and expanded the introduction.
Data Availability
All data produced are available online at: https://wonder.cdc.gov/controller/saved/D176/D408F378
